Eye protection during sclerotherapy.
D004932:Esophageal and Gastric Varices / Q000628:therapy; D005123:Eye / Q000187:drug effects*; D005135:Eye Protective Devices; D005227:Fatty Acids / Q000009:adverse effects*; D006471:Gastrointestinal Hemorrhage / Q000628:therapy; D006801:Humans; D011482:Protective Devices; D012597:Sclerosing Solutions / Q000627:therapeutic use*; D012976:Sodium Morrhuate / Q000009:adverse effects*
D005227:Fatty Acids; D012597:Sclerosing Solutions; D012976:Sodium Morrhuate